Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoh Takekuma

Showing results (11-20 of 186) with videos related to

Pageof 19
Sort By:
Scientific Reports|December 3, 2021
Impact of reducing day 1 dexamethasone dose in anthracycline-containing regimens on acute gastrointestinal symptoms associated with breast cancer treatmentYoshitaka Saito, Yoh Takekuma, Takashi Takeshita, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 10, 2022
Risk factor analysis for regorafenib-induced severe hypertension in metastatic colorectal cancer treatmentYoshitaka Saito, Yoh Takekuma, Yoshito Komatsu, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 19, 2020
Transfer of orally administered hyaluronan to the lymphYuki Sato, Tatsuru Joumura, Yoh Takekuma, et al.
Case Reports in Oncology|August 11, 2022
Combination of Mirogabalin and Duloxetine Attenuates Peripheral Neuropathy by Eribulin: A Novel Case ReportYoshitaka Saito, Yoh Takekuma, Tomohiro Oshino, et al.
Biological & Pharmaceutical Bulletin|February 1, 2023
Usefulness of the Albumin-Bilirubin Score in Determining the Initial Dose of Voriconazole for Patients with Liver CirrhosisShunsuke Nashimoto, Shungo Imai, Mitsuru Sugawara, et al.
International Journal of Clinical Oncology|July 2, 2026
Prediction of chemotherapy-induced nausea during irinotecan-based treatment based on prior oxaliplatin-induced symptoms in colorectal cancerYoshitaka Saito, Yoh Takekuma, Yoshito Komatsu, et al.
Case Reports in Oncology|November 1, 2021
Severe Hypertriglyceridemia Induced by Docetaxel: A Novel Case ReportYoshitaka Saito, Yoh Takekuma, Takashi Takeshita, et al.
Antimicrobial Agents and Chemotherapy|June 25, 2004
Absorption of ester prodrugs in Caco-2 and rat intestine modelsXin He, Mitsuru Sugawara, Yoh Takekuma, et al.
Biological & Pharmaceutical Bulletin|July 14, 2012
Schedule-dependent cytotoxicity of etoposide (VP-16) and cyclophosphamide in leukemia cell line K-562Yuki Tazawa, Kazunori Matsumura, Yoh Takekuma, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 11, 2025
Identification of risk factors related to problematic peripheral neuropathy development in gemcitabine and nab-paclitaxel treatment for pancreatic cancerYoshitaka Saito, Yoh Takekuma, Yoshito Komatsu, et al.
Pageof 19

Showing results (11-20 of 186) with videos related to

Sort By:
Pageof 19
Scientific Reports|December 3, 2021
Impact of reducing day 1 dexamethasone dose in anthracycline-containing regimens on acute gastrointestinal symptoms associated with breast cancer treatmentYoshitaka Saito, Yoh Takekuma, Takashi Takeshita, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 10, 2022
Risk factor analysis for regorafenib-induced severe hypertension in metastatic colorectal cancer treatmentYoshitaka Saito, Yoh Takekuma, Yoshito Komatsu, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 19, 2020
Transfer of orally administered hyaluronan to the lymphYuki Sato, Tatsuru Joumura, Yoh Takekuma, et al.
Case Reports in Oncology|August 11, 2022
Combination of Mirogabalin and Duloxetine Attenuates Peripheral Neuropathy by Eribulin: A Novel Case ReportYoshitaka Saito, Yoh Takekuma, Tomohiro Oshino, et al.
Biological & Pharmaceutical Bulletin|February 1, 2023
Usefulness of the Albumin-Bilirubin Score in Determining the Initial Dose of Voriconazole for Patients with Liver CirrhosisShunsuke Nashimoto, Shungo Imai, Mitsuru Sugawara, et al.
International Journal of Clinical Oncology|July 2, 2026
Prediction of chemotherapy-induced nausea during irinotecan-based treatment based on prior oxaliplatin-induced symptoms in colorectal cancerYoshitaka Saito, Yoh Takekuma, Yoshito Komatsu, et al.
Case Reports in Oncology|November 1, 2021
Severe Hypertriglyceridemia Induced by Docetaxel: A Novel Case ReportYoshitaka Saito, Yoh Takekuma, Takashi Takeshita, et al.
Antimicrobial Agents and Chemotherapy|June 25, 2004
Absorption of ester prodrugs in Caco-2 and rat intestine modelsXin He, Mitsuru Sugawara, Yoh Takekuma, et al.
Biological & Pharmaceutical Bulletin|July 14, 2012
Schedule-dependent cytotoxicity of etoposide (VP-16) and cyclophosphamide in leukemia cell line K-562Yuki Tazawa, Kazunori Matsumura, Yoh Takekuma, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 11, 2025
Identification of risk factors related to problematic peripheral neuropathy development in gemcitabine and nab-paclitaxel treatment for pancreatic cancerYoshitaka Saito, Yoh Takekuma, Yoshito Komatsu, et al.
Pageof 19